Can Uterine Fibroids Dissolve on Their Own?

Uterine fibroids can shrink on their own, and in certain life stages they do so reliably, but the word “dissolve” overstates how clean the process is. What actually happens is a slow, sometimes uncomfortable breakdown driven by hormonal shifts, changes in blood supply, or both. Menopause is the most common trigger for natural shrinkage, and pregnancy can also set it off. The catch is that the timeline and degree of shrinkage vary enormously from person to person, and not every fibroid cooperates.

How Menopause Changes the Picture

Fibroids depend heavily on estrogen and progesterone to grow. When your body stops producing those hormones in significant quantities after menopause, fibroids tend to lose their fuel. A ten-year study tracking postmenopausal women found that shrinkage was fastest in the first two years after menopause, with the rate of size reduction significantly outpacing what happened in years three through ten.¹ That initial window is when hormonal levels are dropping most steeply, so it makes sense that fibroids respond quickest during that period.

But how much a fibroid shrinks depends on more than just hormones. The same study found that women with a BMI under 25 saw roughly 25% shrinkage over ten years, while women with a BMI of 25 or higher saw only about 16%. Fat tissue produces estrogen even after menopause, so carrying more body fat keeps fibroids exposed to the hormone they depend on. The number of fibroids also matters: women with a single fibroid experienced about 26% shrinkage, while those with four or more saw only about 15%.¹

So the honest answer for postmenopausal shrinkage is: yes, it happens, but a quarter reduction over a decade is a far cry from “dissolving.” If a fibroid was large enough to cause symptoms before menopause, a 15–25% size reduction may not fully resolve those symptoms, especially pressure or bulk-related complaints. For some women it’s enough; for others it’s merely a modest improvement.

Why Fibroids Often Shrink After Pregnancy

Pregnancy creates a paradoxical situation for fibroids. During pregnancy, rising estrogen levels can make fibroids grow. But after delivery, something interesting happens. The uterus undergoes rapid involution, blood flow patterns change, and hormone levels crash. For many fibroids, that combination is devastating.

One study found that about 72% of women showed fibroid regression of more than 50% after delivery.² A separate study tracking individual fibroids through pregnancy and postpartum found that roughly 37% of fibroids that had been visible on ultrasound before pregnancy were no longer detectable at all on post-delivery imaging. Overall, about 82% of tracked fibroids were either unchanged or smaller after delivery compared to their pre-pregnancy size.³

That 37% vanishing rate is striking. It doesn’t mean those fibroids literally dissolved into nothing overnight, but they shrank below the threshold that ultrasound could detect. For practical purposes, if a fibroid no longer shows up on imaging and isn’t causing symptoms, it’s a non-issue. The postpartum period seems to mimic some of the conditions that medical treatments try to create artificially: reduced blood flow to the uterus, hormonal withdrawal, and uterine contractions that physically compress fibroid tissue.

The Slow Internal Breakdown

When a fibroid does shrink without treatment, the process follows a fairly well-understood biological sequence. Fibroids are made of smooth muscle cells surrounded by a collagen-rich framework. Over time, the collagen accumulates and gradually pushes the muscle cells farther from their blood supply. Starved of nutrients and oxygen, the cells start to atrophy and eventually die. The dead cells are then broken down and recycled through a process that researchers describe as enzymatic rather than the typical immune-cell cleanup you’d see in an infection or injury.⁴

This is why fibroids that shrink naturally don’t just quietly disappear. The breakdown can cause pain, and it often produces changes visible on imaging: the tissue may calcify, become fluid-filled, or develop a cyst-like appearance. Clinicians sometimes call these degenerative changes, and they’re a normal part of the fibroid lifecycle, not a sign that something has gone wrong. In an MRI study of women referred for fibroid treatment, about 5% had fibroids already showing signs of degeneration. Pain, heavy bleeding, and pressure symptoms were all seen in this group, though more than a third of them had no symptoms at all.⁵

Of those women with degenerating fibroids, about 43% had been pregnant within the past two years, reinforcing how tightly pregnancy-related changes and fibroid breakdown are connected.⁵ In most cases, degeneration was managed conservatively without surgery, which is reassuring if you’re experiencing pain from a fibroid that seems to be breaking down on its own.

Spontaneous Expulsion Is Real but Rare

In unusual cases, a fibroid doesn’t just shrink; it detaches from the uterine wall and is expelled through the vagina. This sounds alarming, and it can be, but it’s well-documented in medical literature. Submucosal fibroids, which grow just under the uterine lining, are the type most likely to do this. The process has been reported during the postpartum period, where the conditions of delivery (uterine contractions, reduced blood flow, thinned lining) can essentially push a dying fibroid out.⁶

Most reported cases of fibroid expulsion have followed some form of medical intervention, such as uterine artery embolization or focused ultrasound treatment, rather than happening entirely on their own.⁷ Truly spontaneous expulsion without any prior treatment is rare enough to warrant case reports when it happens. If you experience unusual vaginal passage of tissue, it warrants medical evaluation regardless of your fibroid history, because it can look similar to other conditions that need prompt attention.

Whether Fibroids Grow or Shrink Depends on Who You Are

Fibroid behavior is not uniform across populations. Research tracking fibroid growth in premenopausal women found that Black and white women under 35 had similar growth rates. But as women aged, the trajectories split: white women’s fibroids tended to grow more slowly with age, while Black women’s fibroids did not show the same age-related slowdown.⁸ The practical consequence is that Black women are more likely to accumulate a higher fibroid burden by the time they reach menopause, which can affect how much relief menopause actually provides.

Beyond race, the natural trajectory of any individual fibroid is surprisingly unpredictable. Imaging studies have shown that in the years between pregnancies, fibroids can grow, shrink, or remain stable, and different fibroids in the same uterus can behave differently from each other.⁹ That makes it hard to predict what any particular fibroid will do if you choose watchful waiting. The general direction for most fibroids before menopause is slow growth, but spontaneous regression does happen, and the reasons aren’t always clear.

Genetic makeup also plays a role at the molecular level. Certain mutations, particularly in a gene called MED12, appear to influence how fibroids respond to hormonal treatments. Research suggests that the shrinkage effect of common medications used to treat fibroids depends partly on whether the fibroid carries this mutation.¹⁰ This helps explain why two women with seemingly identical fibroids can respond very differently to the same treatment, or why one woman’s fibroids shrink after menopause while another’s barely budge.

The Vitamin D Question

One of the more interesting findings in fibroid research over the past decade is the consistent link between low vitamin D levels and fibroids. Across fourteen clinical studies involving more than 3,500 participants, every one found an inverse relationship between vitamin D and the presence of fibroids: the lower the vitamin D, the more fibroids.¹¹ That’s a remarkably consistent signal across different study designs and populations.

When researchers tested whether supplementing vitamin D could actually shrink existing fibroids, four out of five clinical studies found that it significantly slowed or inhibited fibroid growth. One trial specifically comparing vitamin D supplementation against placebo in women who were deficient found that fibroids in the supplement group were meaningfully smaller than those in the placebo group.¹²

This doesn’t mean vitamin D is a fibroid cure. The studies so far are relatively small, and the effects are modest compared to surgical or procedural options. But given that vitamin D deficiency is extremely common and supplementation is cheap and safe at reasonable doses, correcting a deficiency seems like a reasonable strategy alongside other management approaches. Other nutritional research has pointed to fruit and vegetable intake and compounds like epigallocatechin gallate (found in green tea) as potentially beneficial, but the evidence there is even more preliminary.¹³

Medical and Procedural Ways to Force Shrinkage

If waiting for natural regression isn’t practical because symptoms are severe, several approaches can shrink fibroids without removing the uterus. The oldest and most studied medical option involves drugs that temporarily suppress estrogen production, creating an artificial menopause-like state. A large Cochrane review found that these drugs reduce uterine volume by a substantial margin and also boost hemoglobin levels in women who’ve become anemic from heavy bleeding.¹⁴ The downside is that they come with side effects typical of estrogen withdrawal: hot flashes, bone density loss, mood changes. They’re generally used as a bridge to surgery rather than a long-term solution.

On the procedural side, uterine artery embolization works by blocking the blood vessels that feed fibroids, essentially starving them. An interventional radiologist threads tiny particles into both uterine arteries, cutting off the fibroid’s supply. The fibroid then undergoes the same kind of ischemic death described earlier, but on an accelerated timeline.¹⁵ Microwave ablation is a newer alternative that uses heat to destroy fibroid tissue directly; a study following patients for up to three years found that 83% of treated fibroids continued shrinking over time, with a median volume reduction of 77%, and 82% of patients reported sustained symptom improvement.¹⁶

These interventions are worth knowing about because they blur the line between “natural shrinkage” and “treatment.” Many of them work by reproducing the same biological conditions that cause fibroids to regress on their own: hormone deprivation or blood supply interruption. The body does the actual work of breaking down the fibroid either way. The intervention just accelerates the timeline.

Stress and Fibroids

The relationship between psychological stress and fibroid presence has been studied, though it’s trickier to pin down than hormonal or nutritional factors. A study examining major life events found that among white women, the prevalence of fibroids was roughly 1.7 times higher in those who had experienced one or two major stressful events, and about 1.9 times higher in those with three or more events, compared to women who hadn’t experienced any. Among Black women, the association between high stress and fibroids was more modest but still present.¹⁷

Stress is known to affect hormone levels through the body’s stress-response system, and since fibroids are hormone-sensitive, a plausible biological connection exists. However, observational studies like this can’t prove that stress causes fibroids to grow, only that the two tend to appear together. Stress reduction on its own is unlikely to make fibroids shrink, but given that chronic stress affects nearly every aspect of reproductive health, it’s a factor worth considering as part of the bigger picture.

When a Changing Fibroid Deserves Closer Scrutiny

Most fibroids are benign and stay that way. But one concern that occasionally arises, particularly when a fibroid changes size rapidly, is the possibility that what appears to be a fibroid is actually a uterine sarcoma, a rare cancer that can look similar on imaging. A study comparing clinical features of sarcoma and fibroids found that women with sarcoma were significantly more likely to have a history of documented rapid growth.¹⁸

This doesn’t mean a growing fibroid is likely to be cancer. Sarcomas are uncommon, and most fibroids that grow quickly are still benign. But it does mean that a fibroid showing unexpected behavior, whether rapid growth, unusual imaging characteristics, or new symptoms in a postmenopausal woman (when fibroids should be shrinking, not growing), warrants further evaluation rather than simple reassurance. MRI can help distinguish between degenerating benign fibroids and more concerning findings, though the overlap in imaging features means that clinical judgment remains important.

The flip side of this concern is also worth stating plainly: a fibroid that is shrinking or degenerating on its own is almost always a good sign. The pain or discomfort that sometimes accompanies degeneration can feel alarming, but it’s the fibroid dying, which is ultimately what you’d want. If you’re monitoring fibroids and they’re getting smaller, that trajectory is reassuring regardless of what’s causing the shrinkage.

1
Cureus. Postmenopausal Shrinkage of Uterine Myomas: A Retrospective Study of 97 Cases Monitored Annually for 10 Years
2
PubMed Central. Postpartum factors and natural fibroid regression
3
Scientific Reports. The association between childbirth, breastfeeding, and uterine fibroids: an observational study
4
PubMed Central. The Life Cycle of the Uterine Fibroid Myocyte
5
PubMed Central. Degeneration of leiomyoma in patients referred for uterine fibroid embolization: incidence, imaging features and clinical characteristics
6
PubMed Central. Spontaneous expulsion of large submucosal uterine fibroid without embolisation – a case study
7
PubMed Central. Spontaneous expulsion of a submucosal uterine fibroid without embolization in a pre-menopausal woman
8
PubMed Central. Growth of uterine leiomyomata among premenopausal black and white women
9
PubMed Central. Natural History of Uterine Fibroids: A Radiological Perspective
10
PubMed. RISING STARS: Role of MED12 mutation in the pathogenesis of uterine fibroids
11
Reproductive Sciences. A Systematic Review of Vitamin D and Fibroids: Pathophysiology, Prevention, and Treatment
12
PubMed Central. The effect of vitamin D supplementation on the size of uterine leiomyoma in women with vitamin D deficiency
13
PubMed Central. The Role of Nutrition in Pathogenesis of Uterine Fibroids
14
PubMed. Preoperative medical therapy before surgery for uterine fibroids
15
PubMed Central. Uterine artery embolization for treatment of symptomatic fibroids: a review of the evidence
16
Taylor & Francis Online / International Journal of Hyperthermia. Long term follow-up of uterine fibroids treated with microwave ablation
17
PubMed Central. The Association between Self-Reported Major Life Events and the Presence of Uterine Fibroids
18
PubMed Central. Clinical Characteristics Differentiating Uterine Sarcoma and Fibroids